Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure.

[1]  J. Loscalzo,et al.  Predictors of improved left ventricular systolic function in an urban cardiomyopathy program. , 2006, The American journal of cardiology.

[2]  Anne L. Taylor,et al.  Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. , 2006, Journal of the American College of Cardiology.

[3]  L. Cupples,et al.  The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. , 2006, Journal of cardiac failure.

[4]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[5]  F. Cappuccio,et al.  Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population , 2004, Journal of hypertension.

[6]  Zhonglin Xie,et al.  Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. , 2004, American journal of hypertension.

[7]  B. Morris,et al.  Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension , 2003, Journal of hypertension.

[8]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[9]  A. Onipinla,et al.  Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites , 2003, Journal of hypertension.

[10]  C. Iwai,et al.  Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy , 2002, Heart.

[11]  K. Weber,et al.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress. , 2002, The American journal of pathology.

[12]  S. Kardia,et al.  Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .

[13]  K. Sliwa,et al.  An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. , 2002, Cardiovascular research.

[14]  T. Ishimitsu,et al.  Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension , 2002, Journal of Human Hypertension.

[15]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[16]  K. Weber Aldosterone in congestive heart failure. , 2001, The New England journal of medicine.

[17]  C. Yancy Heart failure in blacks: Etiologic and epidemiologic differences , 2001, Current cardiology reports.

[18]  C. Yancy Heart failure in African Americans: A cardiovascular enigma , 2000 .

[19]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[20]  L. Tiret,et al.  Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. , 2000, Journal of the American College of Cardiology.

[21]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[22]  F. Soubrier,et al.  Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. , 1999, Hypertension.

[23]  B. Gersh,et al.  Racial differences in the outcome of left ventricular dysfunction. , 1999, The New England journal of medicine.

[24]  J. Connell,et al.  Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. , 1999, Hypertension.

[25]  F. Cambien,et al.  Genetic determination of plasma aldosterone levels in essential hypertension. , 1998, American journal of hypertension.

[26]  P. White,et al.  Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. , 1998, Circulation.

[27]  A. Struthers Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. , 1996, Journal of cardiac failure.

[28]  P. White,et al.  Haplotype analysis of CYP11B2. , 1995, Endocrine research.

[29]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[30]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[32]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.